626 related articles for article (PubMed ID: 11034392)
1. Phosphatidylinositol 3-kinase and NF-kappa B/Rel are at the divergence of CD40-mediated proliferation and survival pathways.
Andjelic S; Hsia C; Suzuki H; Kadowaki T; Koyasu S; Liou HC
J Immunol; 2000 Oct; 165(7):3860-7. PubMed ID: 11034392
[TBL] [Abstract][Full Text] [Related]
2. Antigen-receptor cross-linking and lipopolysaccharide trigger distinct phosphoinositide 3-kinase-dependent pathways to NF-kappa B activation in primary B cells.
Bone H; Williams NA
Int Immunol; 2001 Jun; 13(6):807-16. PubMed ID: 11369709
[TBL] [Abstract][Full Text] [Related]
3. Interferon alpha /beta promotes cell survival by activating nuclear factor kappa B through phosphatidylinositol 3-kinase and Akt.
Yang CH; Murti A; Pfeffer SR; Kim JG; Donner DB; Pfeffer LM
J Biol Chem; 2001 Apr; 276(17):13756-61. PubMed ID: 11278812
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol 3-kinase-dependent mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 and NF-kappa B signaling pathways are required for B cell antigen receptor-mediated cyclin D2 induction in mature B cells.
Piatelli MJ; Wardle C; Blois J; Doughty C; Schram BR; Rothstein TL; Chiles TC
J Immunol; 2004 Mar; 172(5):2753-62. PubMed ID: 14978074
[TBL] [Abstract][Full Text] [Related]
5. Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways.
Zarnegar B; He JQ; Oganesyan G; Hoffmann A; Baltimore D; Cheng G
Proc Natl Acad Sci U S A; 2004 May; 101(21):8108-13. PubMed ID: 15148378
[TBL] [Abstract][Full Text] [Related]
6. B cell receptor (BCR) cross-talk: CD40 engagement creates an alternate pathway for BCR signaling that activates I kappa B kinase/I kappa B alpha/NF-kappa B without the need for PI3K and phospholipase C gamma.
Mizuno T; Rothstein TL
J Immunol; 2005 May; 174(10):6062-70. PubMed ID: 15879100
[TBL] [Abstract][Full Text] [Related]
7. CD40 signaling in B cells regulates the expression of the Pim-1 kinase via the NF-kappa B pathway.
Zhu N; Ramirez LM; Lee RL; Magnuson NS; Bishop GA; Gold MR
J Immunol; 2002 Jan; 168(2):744-54. PubMed ID: 11777968
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the NF-kappa B and PI 3-kinase/Akt survival pathways in nerve growth factor-dependent neurons.
Sarmiere PD; Freeman RS
Mol Cell Neurosci; 2001 Sep; 18(3):320-31. PubMed ID: 11591132
[TBL] [Abstract][Full Text] [Related]
9. CD40 induces human multiple myeloma cell migration via phosphatidylinositol 3-kinase/AKT/NF-kappa B signaling.
Tai YT; Podar K; Mitsiades N; Lin B; Mitsiades C; Gupta D; Akiyama M; Catley L; Hideshima T; Munshi NC; Treon SP; Anderson KC
Blood; 2003 Apr; 101(7):2762-9. PubMed ID: 12433678
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells.
Das R; Mahabeleshwar GH; Kundu GC
J Biol Chem; 2003 Aug; 278(31):28593-606. PubMed ID: 12771144
[TBL] [Abstract][Full Text] [Related]
11. c-Rel regulation of the cell cycle in primary mouse B lymphocytes.
Hsia CY; Cheng S; Owyang AM; Dowdy SF; Liou HC
Int Immunol; 2002 Aug; 14(8):905-16. PubMed ID: 12147627
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone exerts antiapoptotic and proliferative effects through two different pathways involving nuclear factor-kappaB and phosphatidylinositol 3-kinase.
Jeay S; Sonenshein GE; Kelly PA; Postel-Vinay MC; Baixeras E
Endocrinology; 2001 Jan; 142(1):147-56. PubMed ID: 11145577
[TBL] [Abstract][Full Text] [Related]
13. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
[TBL] [Abstract][Full Text] [Related]
14. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.
Bouscary D; Pene F; Claessens YE; Muller O; Chrétien S; Fontenay-Roupie M; Gisselbrecht S; Mayeux P; Lacombe C
Blood; 2003 May; 101(9):3436-43. PubMed ID: 12506011
[TBL] [Abstract][Full Text] [Related]
15. Akt protects mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis through NK-kappa B activation.
Hatano E; Brenner DA
Am J Physiol Gastrointest Liver Physiol; 2001 Dec; 281(6):G1357-68. PubMed ID: 11705740
[TBL] [Abstract][Full Text] [Related]
16. Distinctive regulation and function of PI 3K/Akt and MAPKs in doxorubicin-induced apoptosis of human lung adenocarcinoma cells.
Zhao Y; You H; Yang Y; Wei L; Zhang X; Yao L; Fan D; Yu Q
J Cell Biochem; 2004 Feb; 91(3):621-32. PubMed ID: 14755690
[TBL] [Abstract][Full Text] [Related]
17. B cell antigen receptor-induced activation of Akt promotes B cell survival and is dependent on Syk kinase.
Pogue SL; Kurosaki T; Bolen J; Herbst R
J Immunol; 2000 Aug; 165(3):1300-6. PubMed ID: 10903730
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of nuclear factor kappaB and phosphatidylinositol 3-kinase/Akt is essential for massive hepatocyte apoptosis induced by tumor necrosis factor alpha in mice.
Imose M; Nagaki M; Naiki T; Osawa Y; Brenner DA; Asano T; Hayashi H; Kato T; Moriwaki H
Liver Int; 2003 Oct; 23(5):386-96. PubMed ID: 14708901
[TBL] [Abstract][Full Text] [Related]
19. Thrombopoietin regulates Bcl-xL gene expression through Stat5 and phosphatidylinositol 3-kinase activation pathways.
Kirito K; Watanabe T; Sawada K; Endo H; Ozawa K; Komatsu N
J Biol Chem; 2002 Mar; 277(10):8329-37. PubMed ID: 11756417
[TBL] [Abstract][Full Text] [Related]
20. PI-3K/Akt and NF-kappaB/IkappaBalpha pathways are activated in Jurkat T cells in response to TRAIL treatment.
Zauli G; Sancilio S; Cataldi A; Sabatini N; Bosco D; Di Pietro R
J Cell Physiol; 2005 Mar; 202(3):900-11. PubMed ID: 15389633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
